Cargando…
Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19
BACKGROUND: Since the beginning of COVID-19 pandemic, there has been a widespread use of remdesivir in adults and children. There is little known information about remdesivir's role in reducing 30-day readmissions after hospitalization with COVID-19. This study aimed to determine whether treatm...
Autores principales: | Finn, Arkadiy, Jindal, Atin, Andrea, Sarah B., Selvaraj, Vijairam, Dapaah-Afriyie, Kwame |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830144/ https://www.ncbi.nlm.nih.gov/pubmed/35151637 http://dx.doi.org/10.1016/j.amjms.2022.01.021 |
Ejemplares similares
-
Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Complete heart block associated with Remdesivir in COVID-19: a case report
por: Selvaraj, Vijairam, et al.
Publicado: (2021) -
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
por: Selvaraj, Vijairam, et al.
Publicado: (2021)